Ultra-Low-Priced Lithium Stock Offers Unlimited Upside in Global EV Boom

From Resource Stock Digest | Ad

Lithium batteries are supplying our planet with clean reliable energy. EVs, laptops, cell phones...you name it. The Smart Money is going into the future suppliers of lithium like this US$0.15 stock that just secured a game-changing lithium asset.

Details Here.

ALDX Insider Trading (Aldeyra Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.00%

Insider Buying (Last 12 Months): $45,664,999.50

Insider Selling (Last 12 Months): $0.00

Aldeyra Therapeutics Insider Trading History Chart

Aldeyra Therapeutics Share Price & Price History

^$12.48

▲ +0.43 (3.57%)

As of 05/7/2021 01:00 AM ET

Days: 30 | 90 | 365

Legendary Crypto Analyst Names 3 Coins to Buy Instead of Coinbase

From IPM | Ad

Matt McCall’s crypto portfolio has delivered multiple 1,000% winners in just months…

Now he’s naming 3 tokens he believes folks should own instead of the Coinbase stock in a free report.

Click here to get your copy today.

Aldeyra Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/3/2021	Perceptive Advisors Llc	Major Shareholder	Buy	1,200,000	$12.50	$15,000,000.00
1/19/2021	Perceptive Advisors Llc	Major Shareholder	Buy	1,368,421	$9.50	$12,999,999.50
1/7/2021	Perceptive Advisors Llc	Major Shareholder	Buy	500,000	$8.13	$4,065,000.00
7/9/2020	Perceptive Advisors Llc	Major Shareholder	Buy	3,200,000	$4.25	$13,600,000.00
3/16/2020	Richard Douglas	Director	Buy	40,000	$2.75	$110,000.00	125,000
12/16/2019	Todd C Brady	CEO	Buy	20,000	$5.83	$116,600.00	652,216
9/30/2019	Todd C Brady	CEO	Buy	8,710	$5.68	$49,472.80	632,216
9/23/2019	Todd C Brady	CEO	Buy	8,680	$5.81	$50,430.80	623,506
9/18/2019	Todd C Brady	CEO	Buy	14,288	$5.91	$84,442.08	614,826
9/17/2019	Ben Bronstein	Director	Buy	1,700	$5.85	$9,945.00	18,644
9/16/2019	Todd C Brady	CEO	Buy	3,000	$6.03	$18,090.00	588,991
9/12/2019	Richard Douglas	Director	Buy	10,000	$6.03	$60,300.00	70,000
9/10/2019	Richard Douglas	Director	Buy	20,000	$5.00	$100,000.00	70,000
9/9/2019	Todd C. Brady	CEO	Buy	10,000	$4.89	$48,900.00	50,000
9/5/2019	David Mcmullin	Insider	Buy	4,329	$4.68	$20,259.72
9/5/2019	Joshua Reed	CFO	Buy	3,200	$4.71	$15,072.00
3/26/2019	Jesse I Treu	Director	Sell	96,743	$10.01	$968,397.43

SEC Filings (Institutional Ownership Changes) for Aldeyra Therapeutics (NASDAQ:ALDX)

61.29% of Aldeyra Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aldeyra Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/7/2021	BlackRock Inc.	1,053,328	$12.51M	0.0%	+35.0%	2.215%
5/7/2021	BNP Paribas Arbitrage SA	31,892	$0.38M	0.0%	N/A	0.067%
5/7/2021	Alps Advisors Inc.	70,227	$0.83M	0.0%	+1.5%	0.148%
5/6/2021	Johnson & Johnson Innovation JJDC Inc.	394,834	$4.69M	0.6%	-33.6%	0.830%
5/6/2021	Quantitative Systematic Strategies LLC	18,902	$0.23M	0.0%	-25.8%	0.040%
5/6/2021	Altium Capital Management LP	548,225	$6.51M	1.8%	N/A	1.153%
4/26/2021	Assenagon Asset Management S.A.	53,774	$0.64M	0.0%	-80.0%	0.113%
4/19/2021	International Assets Investment Management LLC	37,355	$0.31M	0.0%	+36.8%	0.079%
4/15/2021	First Midwest Bank Trust Division	62,331	$0.74M	0.1%	N/A	0.132%
4/14/2021	Mesirow Financial Investment Management Inc.	63,634	$0.76M	2.1%	-1.6%	0.135%
4/5/2021	Pacer Advisors Inc.	3,810	$45K	0.0%	N/A	0.008%
3/8/2021	Dimensional Fund Advisors LP	268,032	$1.84M	0.0%	+17.6%	0.690%
2/25/2021	Dimensional Fund Advisors LP	268,032	$1.84M	0.0%	+17.6%	0.690%
2/24/2021	Virtu Financial LLC	13,428	$92K	0.0%	-52.6%	0.035%
2/18/2021	Verition Fund Management LLC	196,754	$1.35M	0.0%	-33.6%	0.507%
2/18/2021	Ghost Tree Capital LLC	650,000	$4.46M	0.9%	-48.0%	1.674%
2/17/2021	Jane Street Group LLC	80,560	$0.55M	0.0%	+360.1%	0.208%
2/16/2021	One68 Global Capital LLC	17,899	$0.12M	0.2%	N/A	0.046%
2/16/2021	New York Life Investments Alternatives	55,821	$0.38M	0.3%	N/A	0.144%
2/16/2021	Avidity Partners Management LP	1,435,000	$9.84M	0.3%	+0.3%	3.697%
2/16/2021	ExodusPoint Capital Management LP	139,520	$0.96M	0.0%	+1,121.5%	0.359%
2/16/2021	Acuta Capital Partners LLC	192,500	$1.32M	0.4%	-88.3%	0.496%
2/11/2021	Northern Trust Corp	73,364	$0.50M	0.0%	-2.7%	0.189%
2/11/2021	Citigroup Inc.	44,193	$0.30M	0.0%	+95.0%	0.114%
2/10/2021	Renaissance Technologies LLC	53,800	$0.37M	0.0%	N/A	0.139%
2/9/2021	Wells Fargo & Company MN	7,253	$50K	0.0%	+2,960.3%	0.019%
2/9/2021	Bank of New York Mellon Corp	56,674	$0.39M	0.0%	+264.5%	0.146%
2/9/2021	Quantitative Systematic Strategies LLC	25,475	$0.18M	0.0%	-40.3%	0.066%
2/8/2021	Russell Investments Group Ltd.	46,802	$0.32M	0.0%	-4.5%	0.121%
2/5/2021	BlackRock Inc.	780,304	$5.35M	0.0%	+3.9%	2.010%
2/5/2021	SG Americas Securities LLC	26,578	$0.18M	0.0%	N/A	0.068%
2/4/2021	GSA Capital Partners LLP	61,220	$0.42M	0.1%	+140.1%	0.158%
2/2/2021	First Trust Advisors LP	93,920	$0.64M	0.0%	-3.9%	0.242%
2/1/2021	Assenagon Asset Management S.A.	269,183	$1.85M	0.0%	-43.2%	0.693%
1/22/2021	International Assets Investment Management LLC	27,315	$0.19M	0.0%	N/A	0.070%
1/20/2021	Kestra Advisory Services LLC	19,767	$0.14M	0.0%	N/A	0.051%
12/11/2020	Virtu Financial LLC	28,324	$0.21M	0.0%	N/A	0.073%
11/19/2020	Schonfeld Strategic Advisors LLC	108,100	$0.80M	0.0%	-21.4%	0.278%
11/17/2020	Old Well Partners LLC	17,575	$0.13M	0.1%	N/A	0.045%
11/17/2020	Jane Street Group LLC	17,509	$0.13M	0.0%	-86.7%	0.045%
11/17/2020	Schonfeld Strategic Advisors LLC	108,100	$0.80M	0.0%	-21.4%	0.278%
11/16/2020	Point72 Asset Management L.P.	641,918	$4.76M	0.0%	N/A	1.654%
11/16/2020	Squarepoint Ops LLC	39,349	$0.29M	0.0%	-73.0%	0.101%
11/16/2020	Perceptive Advisors LLC	6,285,458	$46.58M	0.7%	+103.7%	16.191%
11/16/2020	ExodusPoint Capital Management LP	11,422	$85K	0.0%	-12.7%	0.029%
11/13/2020	Morgan Stanley	5,400	$40K	0.0%	-97.5%	0.014%
11/13/2020	Cetera Advisor Networks LLC	11,188	$83K	0.0%	N/A	0.029%
11/9/2020	National Asset Management Inc.	10,250	$76K	0.0%	N/A	0.027%
11/9/2020	Quantitative Systematic Strategies LLC	42,655	$0.32M	0.1%	+15.4%	0.110%
11/6/2020	BlackRock Inc.	751,144	$5.57M	0.0%	+55.3%	1.944%
11/6/2020	GSA Capital Partners LLP	25,503	$0.19M	0.0%	N/A	0.066%
11/5/2020	California Public Employees Retirement System	65,800	$0.49M	0.0%	N/A	0.170%
11/5/2020	First Trust Advisors LP	97,692	$0.72M	0.0%	N/A	0.253%
11/4/2020	Windsor Creek Advisors LLC	20,580	$0.15M	0.0%	N/A	0.053%
10/13/2020	Mesirow Financial Investment Management Inc.	64,391	$0.48M	2.0%	-29.7%	0.167%
10/8/2020	Hikari Power Ltd	20,020	$0.15M	0.0%	-50.0%	0.052%
10/7/2020	Assenagon Asset Management S.A.	474,276	$3.51M	0.0%	N/A	1.228%
9/15/2020	Two Sigma Advisers LP	77,000	$0.32M	0.0%	+124.5%	0.199%
9/15/2020	Schonfeld Strategic Advisors LLC	137,600	$0.57M	0.0%	N/A	0.356%
8/24/2020	FMR LLC	612,133	$2.55M	0.0%	-49.3%	1.585%
8/17/2020	Jacobs Levy Equity Management Inc.	305,039	$1.27M	0.0%	+578.4%	0.790%
8/17/2020	Jane Street Group LLC	131,590	$0.55M	0.0%	N/A	0.341%
8/17/2020	Public Employees Retirement System of Ohio	11,647	$49K	0.0%	N/A	0.030%
8/14/2020	Verition Fund Management LLC	22,000	$92K	0.0%	N/A	0.074%
8/14/2020	Stifel Financial Corp	114,373	$0.48M	0.0%	+65.3%	0.384%
8/14/2020	Prosight Management LP	1,620,200	$6.76M	2.9%	-20.4%	5.439%
8/13/2020	FMR LLC	612,133	$2.55M	0.0%	-49.3%	2.055%
8/12/2020	Algert Global LLC	23,530	$98K	0.0%	-22.7%	0.079%
8/12/2020	Goldman Sachs Group Inc.	37,073	$0.16M	0.0%	+32.6%	0.124%
8/12/2020	Bank of New York Mellon Corp	15,548	$65K	0.0%	-76.7%	0.052%
8/12/2020	State of Wisconsin Investment Board	22,100	$92K	0.0%	N/A	0.074%
8/12/2020	Blair William & Co. IL	10,850	$45K	0.0%	N/A	0.036%
8/5/2020	Russell Investments Group Ltd.	42,204	$0.18M	0.0%	N/A	0.142%
8/4/2020	Quantitative Systematic Strategies LLC	36,963	$0.15M	0.0%	N/A	0.124%
7/22/2020	Mesirow Financial Investment Management Inc.	91,566	$0.38M	1.8%	-2.4%	0.307%
7/7/2020	Woodstock Corp	148,072	$0.62M	0.1%	+10.7%	0.497%
6/19/2020	State Street Corp	403,009	$1M	0.0%	-3.4%	1.353%
5/15/2020	Squarepoint Ops LLC	30,508	$75K	0.0%	N/A	0.102%
5/15/2020	Weiss Multi Strategy Advisers LLC	147,257	$0.36M	0.0%	-26.4%	0.494%
5/15/2020	Two Sigma Investments LP	78,560	$0.19M	0.0%	N/A	0.264%
5/15/2020	Two Sigma Advisers LP	34,300	$85K	0.0%	+239.6%	0.115%
5/15/2020	Prosight Management LP	2,035,340	$5.03M	2.3%	+42.5%	6.832%
5/14/2020	Geode Capital Management LLC	332,754	$0.82M	0.0%	+0.9%	1.117%
5/14/2020	Deutsche Bank AG	16,457	$40K	0.0%	-51.5%	0.055%
5/14/2020	Nuveen Asset Management LLC	61,063	$0.15M	0.0%	-56.2%	0.205%
5/13/2020	Parametric Portfolio Associates LLC	18,459	$46K	0.0%	-31.2%	0.062%
5/13/2020	Connor Clark & Lunn Investment Management Ltd.	99,722	$0.25M	0.0%	+11.4%	0.335%
5/13/2020	Tobias Financial Advisors Inc.	34,173	$84K	0.1%	N/A	0.115%
5/12/2020	Spark Investment Management LLC	16,300	$40K	0.0%	N/A	0.055%
5/12/2020	JPMorgan Chase & Co.	63,340	$0.16M	0.0%	+756.6%	0.213%
5/11/2020	Acadian Asset Management LLC	33,098	$82K	0.0%	+559.5%	0.111%
5/11/2020	State Street Corp	403,009	$1M	0.0%	-3.4%	1.353%
5/11/2020	Private Advisors LLC	137,230	$0.34M	0.3%	+55.4%	0.461%
5/6/2020	Bank of New York Mellon Corp	66,794	$0.17M	0.0%	-10.1%	0.225%
5/1/2020	BlackRock Inc.	1,614,192	$3.99M	0.0%	+1.9%	5.440%
5/1/2020	UBS Group AG	15,154	$37K	0.0%	-63.6%	0.051%
4/23/2020	Hikari Power Ltd	60,020	$0.15M	0.0%	-25.0%	0.202%
4/9/2020	Mesirow Financial Investment Management Inc.	93,863	$0.23M	1.5%	+40.4%	0.316%
3/5/2020	Nuveen Asset Management LLC	139,382	$0.81M	0.0%	+87.0%	0.499%
3/2/2020	Connor Clark & Lunn Investment Management Ltd.	89,497	$0.52M	0.0%	+16.0%	0.320%

Data available starting January 2016

Aldeyra Therapeutics is a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases. Two of the company’s lead compounds, reproxalap and ADX-629, target reactive aldehyde species (RASP), which are elevated in ocular and systemic inflammatory disease, leading to elevated levels of cytokine release via activation of a broad array of inflammatory factors, including NF-κB, inflammasomes, and Scavenger Receptor A. Reproxalap is being evaluated in Phase 3 clinical trials in patients with dry eye disease and allergic conjunctivitis. The company’s clinical pipeline also includes ADX-2191, a dihydrofolate reductase inhibitor in Phase 3 testing for proliferative vitreoretinopathy, and ADX-1612, a chaperome inhibitor in Phase 2 testing for COVID-19 and ovarian cancer.

Today's Range

Now: $12.48

$12.21

$12.74

50 Day Range

MA: $11.82

$10.44

$14.85

52 Week Range

Now: $12.48

$2.73

$15.95

Volume

1,319,170 shs

Average Volume

2,210,809 shs

Market Capitalization

$593.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.86

Who are the company insiders with the largest holdings of Aldeyra Therapeutics?

Aldeyra Therapeutics' top insider investors include:

Todd C Brady (CEO)
Richard Douglas (Director)
Todd C Brady (CEO)
Ben Bronstein (Director)
David Mcmullin (Insider)
Joshua Reed (CFO)
Perceptive Advisors Llc (Major Shareholder)

Who are the major institutional investors of Aldeyra Therapeutics?

Aldeyra Therapeutics' top institutional shareholders include:

BlackRock Inc. — 2.22%
Altium Capital Management LP — 1.15%
Johnson & Johnson Innovation JJDC Inc. — 0.83%
Alps Advisors Inc. — 0.15%
Mesirow Financial Investment Management Inc. — 0.13%
First Midwest Bank Trust Division — 0.13%

Which major investors are selling Aldeyra Therapeutics stock?

In the last quarter, ALDX stock was sold by these institutional investors:

Assenagon Asset Management S.A.
Johnson & Johnson Innovation JJDC Inc.
Quantitative Systematic Strategies LLC
Mesirow Financial Investment Management Inc.

Which major investors are buying Aldeyra Therapeutics stock?

Within the previous quarter, ALDX stock was acquired by institutional investors including:

Altium Capital Management LP
BlackRock Inc.
First Midwest Bank Trust Division
BNP Paribas Arbitrage SA
International Assets Investment Management LLC
Pacer Advisors Inc.
Alps Advisors Inc.

During the last year, these company insiders have bought Aldeyra Therapeutics stock:

Todd C Brady (CEO)
Richard Douglas (Director)
Todd C Brady (CEO)
Ben Bronstein (Director)
David Mcmullin (Insider)
Joshua Reed (CFO)
Perceptive Advisors Llc (Major Shareholder)

Investors Lining Up for 20X Gains on Massive Canadian Copper Find

From Resource Stock Digest | Ad

That’s precisely what happens when an exploration dream-team plants its flag on Canada’s richest copper discovery in years. Well-timed investors still have an opportunity to get in below US$0.50 per share as copper blasts through 10-year highs.

Click here for details...